Who is sponsoring NCT06757816?

NCT06757816 is sponsored by Assiut University.

What drugs are being tested in NCT06757816?

Interventions in NCT06757816: accessory rod and iliac fixation for distal augmentation for S1 fixation..

What condition does NCT06757816 study?

NCT06757816 studies Lumbosacral.

Is NCT06757816 still recruiting?

NCT06757816 is currently not yet recruiting. Last updated 7 January 2025.

Last reviewed 2025-01-07 · How we verify

NCT06757816

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Outcome of Accessory Rods and Ilic Fixation for Distal Augmentation of S1 Fixation

Not yet recruiting NA Last updated 7 January 2025

What this trial tests

NA trial testing accessory rod and iliac fixation for distal augmentation for S1 fixation. in Lumbosacral in 20 participants. Not yet recruiting.

Timeline

30 January 2025

Primary endpoint
31 December 2025

30 April 2026

Quick facts

Lead sponsor	Assiut University
Phase	NA
Status	Not yet recruiting
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	30 January 2025
Primary completion	31 December 2025
Estimated completion	30 April 2026
Sites	1 location across Egypt

Drugs / interventions tested

accessory rod and iliac fixation for distal augmentation for S1 fixation.

Conditions studied

Lumbosacral — all drugs for Lumbosacral →

Sponsor

Assiut University

Who can join

Adults 15 to 90, any sex, with Lumbosacral. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To assess radiological and clinical outcome of use of accessory rod and iliac fixation for distal augmentation of L1 fixation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06757816 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 7 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06757816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing